Simplified Chinese
Minhai Biotechnology was named to the 2019 Top 100 List of Technological Innovation among Beijing Private Enterprises.
Release date:
2019-11-15
Author:
Contributed by the General Office
Source:
Abstract
Following its inaugural release last year, this morning (November 15), the Beijing Federation of Industry and Commerce once again unveiled the 2019 rankings for the “Top 100 Private Enterprises in Beijing,” the “Top 100 Private Enterprises in Technological Innovation in Beijing,” the “Top 100 Private Enterprises in the Cultural Industries in Beijing,” and the “Top 100 Private Enterprises in Corporate Social Responsibility in Beijing,” along with the accompanying research reports. As a leading enterprise in the biopharmaceutical sector, Minhai Bio was successfully named to the “2019 Top 100 Private Enterprises in Technological Innovation in Beijing.” Zheng Haifa, General Manager of Minhai Bio, took to the stage to accept the award on behalf of ten outstanding companies and was warmly received by city leaders.
A relevant official from the Beijing Federation of Industry and Commerce stated that in 2019, the threshold for inclusion in the Top 100 Private Enterprises in Beijing was further raised. Seven new bonus‑point criteria were added—namely, “per capita GDP,” “total labor productivity,” and the proportion of the population with a college degree or higher—thereby reinforcing the principle of selecting companies based on their overall strength rather than simply ranking them among the top 100. At the same time, seven veto‑type criteria were introduced, covering issues such as “serious ecological damage,” “major environmental pollution incidents,” and “serious production safety accidents,” thereby elevating the city’s benchmark for excellence and placing greater emphasis on high‑quality development. The list also exhibits notable features such as innovation‑driven upgrading, structural optimization, and increased investment in research and development.
Minhai Biologics is dedicated to the research, development, production, and marketing of human vaccines. Guided by the corporate mission “Creating better vaccines to benefit human health,” the company has consistently pursued innovation and boldly explored new frontiers. This year, Minhai Biologics was recognized on the “2019 Top 100 List of Technological Innovation among Beijing Private Enterprises,” a testament to its robust capabilities in scientific and technological advancement.
Keywords:
Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09
Contact Information
Customer Service Hotline
4001899806
Phone number
010-59613600
Official Website
Company Address
No. 35 Simiao Road and No. 25 Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing
WeChat Official Account